Functional Dyspepsia: Mechanisms of Symptom Generation and Appropriate Management of Patients

Gastroenterology Clinics of North America

Volumn 36, Issue 3, 2007, Pages 649-664

  Camilleri, Michael ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; BUSPIRONE; CISAPRIDE; CLONIDINE; DOMPERIDONE; ITOPRIDE; METOCLOPRAMIDE; SILDENAFIL; SUMATRIPTAN; TEGASEROD;

ALGORITHM; CLINICAL TRIAL; DRUG THERAPY; DYSPEPSIA; HUMAN; PATHOPHYSIOLOGY; PATIENT CARE; REVIEW; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH PARESIS;

BEHAVIOR THERAPY; DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROPARESIS; HELICOBACTER INFECTIONS; HUMANS; PROGNOSIS; SEROTONIN AGONISTS;

EID: 35348889820     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2007.07.001     Document Type: Review

References (87)

1. Tack J., Caenepeel P., Arts J., et al. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 54 (2005) 1370-1376
2. Moayyedi P., Soo S., Deeks J., et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 1 (2005) CD002096
3. Moayyedi P., Soo S., Deeks J., et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 4 (2004) CD001960
4. Talley N.J., Stanghellini V., Heading R.C., et al. Functional gastroduodenal disorders. Gut 45 (1999) II37-II42
5. Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 130 (2006) 1466-1479
6. Tack J., Bisschops R., and Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127 (2004) 1239-1255
7. Camiilleri M., Dubois D., Coulie B., et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States (results of the US Upper Gastrointestinal Study). Clin Gastroenterol Hepatol 3 (2005) 543-552
8. Castillo E.J., Camilleri M., Locke G.R., et al. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2 (2004) 985-996
9. Stanghellini V., Tosetti C., Paternico A., et al. Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 94 (1999) 2080-2085
10. Tucci A., Corinaldesi R., Stanghellini V., et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 103 (1992) 768-774
11. Danesh J., Lawrence M., Murphy M., et al. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 160 (2000) 1192-1198
12. Thumshirn M., Camilleri M., Saslow S.B., et al. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 44 (1999) 55-64
13. Rhee P.L., Kim Y.H., Son H.J., et al. Lack of association of Helicobacter pylori infection with gastric hypersensitivity or delayed gastric emptying in functional dyspepsia. Am J Gastroenterol 94 (1999) 3165-3169
14. Sarnelli G., Janssens J., and Tack J. Helicobacter pylori is not associated with symptoms and pathophysiological mechanisms of functional dyspepsia. Dig Dis Sci 48 (2003) 2229-2236
15. Greydanus M.P., Vassallo M., Camilleri M., et al. Neurohormonal factors in functional dyspepsia (insights on pathophysiological mechanisms). Gastroenterology 100 (1991) 1311-1318
16. Sarnelli G., Caenepeel P., Geypens B., et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 98 (2003) 783-788
17. Maes B.D., Ghoos Y.F., Hiele M.I., et al. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 42 (1997) 1158-1162
18. Stanghellini V., Tosetti C., Paternico A., et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 110 (1996) 1036-1042
19. Perri F., Clemente R., Festa V., et al. Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol 93 (1998) 2082-2088
20. Talley N.J., Verlinden M., and Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?. Am J Gastroenterol 96 (2001) 1422-1428
21. Couturier O., Bodet-Milin C., Querellou S., et al. Gastric scintigraphy with a liquid-solid radiolabeled meal: performances of solid and liquid parameters. Nucl Med Commun 25 (2004) 1143-1150
22. Hjelland I.E., Hausken T., Svebak S., et al. Vagal tone and meal-induced abdominal symptoms in healthy subjects. Digestion 65 (2002) 172-176
23. Holtmann G., Goebell H., Jockenhoevel F., et al. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut 42 (1998) 501-556
24. Troncon L.E., Thompson D.G., Ahluwalia N.K., et al. Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut 37 (1995) 17-22
25. Ricci R., Bontempo I., La Bella A., et al. Dyspeptic symptoms and gastric antrum distribution: an ultrasonographic study. Ital J Gastroenterol 19 (1987) 215-217
26. Hausken T., and Berstad A. Wide gastric antrum in patients with non-ulcer dyspepsia: effect of cisapride. Scand J Gastroenterol 27 (1992) 427-432
27. Troncon L.E.A., Bennett R.J.M., Ahluwalia N.K., et al. Abnormal distribution of food during gastric emptying in functional dyspepsia patients. Gut 35 (1994) 327-332
28. Gilja O.H., Hausken T., Wilhelmsen I., et al. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 41 (1996) 689-696
29. Tack J., Piessevaux H., Coulie B., et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115 (1998) 1346-1352
30. Salet G.A.M., Samsom M., Roelofs J.M.M., et al. Responses to gastric distention in functional dyspepsia. Gut 42 (1998) 823-829
31. Kim D.Y., Delgado-Aros S., Camilleri M., et al. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 96 (2001) 3099-3105
32. Boeckxstaens G.E., Hirsch D.P., Kuiken S.D., et al. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 97 (2002) 40-48
33. Piessevaux H., Tack J., Walrand S., et al. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil 15 (2003) 447-455
34. Bredenoord A.J., Chial H.J., Camilleri M., et al. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 1 (2003) 264-272
35. Simren M., Vos R., Janssens J., et al. Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia: relevance to symptoms. Am J Gastroenterol 98 (2003) 2169-2175
36. Tack J., Caenepeel P., Corsetti M., et al. Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 127 (2004) 1058-1066
37. Tack J., Caenepeel P., Fischler B., et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121 (2001) 526-535
38. Lemann M., Dederding J.P., Flourie B., et al. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia: the irritable stomach syndrome. Dig Dis Sci 36 (1991) 1249-1254
39. Bradette M., Pare P., Douville P., et al. Visceral perception in health and functional dyspepsia: crossover study of gastric distensions with placebo and domperidone. Dig Dis Sci 36 (1991) 52-58
40. Mearin F., Cucala M., Azpiroz F., et al. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 101 (1991) 999-1006
41. Mertz H., Fullerton S., Naliboff B., et al. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 42 (1998) 814-822
42. Lee K.J., Vos R., Janssens J., et al. Differences in the sensorimotor response to distension between the proximal and distal stomach in humans. Gut 53 (2004) 938-943
43. Rhee P.L., Kim Y.H., Son H.J., et al. Evaluation of individual symptoms cannot predict presence of gastric hypersensitivity in functional dyspepsia. Dig Dis Sci 45 (2000) 1680-1684
44. Tack J., Bisschops R., Caenepeel P., et al. Pathophysiological relevance of fasting versus postprandial sensitivity testing in functional dyspepsia. Gastroenterology 122 (2002) A301
45. Houghton L.A., Mangnall Y.F., Dwivedi A., et al. Increased nutrient sensitivity in a subgroup of patients with nonulcer dyspepsia (NUD). Gut 31 (1990) A1185
46. Barbera R., Feinle C., and Read N.W. Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 40 (1995) 1636-1641
47. Barbera R., Feinle C., and Read N.W. Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 7 (1995) 1051-1057
48. Zerbib F., Bruley Des Varannes S., Scarpignato C., et al. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol 275 (1998) G1266-G1273
49. DeMarchi B., Vos R., Deprez P., et al. Influence of a lipase inhibitor on gastric sensitivity and accommodation to an orally ingested meal. Aliment Pharmacol Ther 19 (2004) 1261-1268
50. Samsom M., Verhagen M.A., van Berge Henegouwen G.P., et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 116 (1999) 515-520
51. Lee K., Demarchi B., Demedts I., et al. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol 99 (2004) 1765-1773
52. Wilhelmsen I., Haug T.T., Ursin H., et al. Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer: significance of somatization. Dig Dis Sci 40 (1995) 1105-1111
53. Bennett E.J., Kellow J.E., Cowan H., et al. Suppression of anger and gastric emptying in patients with functional dyspepsia. Scand J Gastroenterol 27 (1992) 869-874
54. Haug T.T., Svebak S., Hausken T., et al. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med 56 (1994) 181-186
55. Delgado-Aros S., Camilleri M., Cremonini F., et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 127 (2004) 1685-1694
56. Fischler B., Tack J., De Gucht V., et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 124 (2003) 903-910
57. Karamanolis G., Caenepeel P., Arts J., et al. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 130 (2006) 296-303
58. Mundt M.W., Hausken T., and Samsom M. Effect of intragastric barostat bag on proximal and distal gastric accommodation in response to liquid meal. Am J Physiol 283 (2002) G681-G716
59. Caldarella M.P., Azpiroz F., and Malagelada J.R. Antro-fundic dysfunctions in functional dyspepsia. Gastroenterology 124 (2003) 1220-1229
60. Mundt M.W., Hausken T., Smout A.J., et al. Relationships between gastric accommodation and gastrointestinal sensations in healthy volunteers: a study using the barostat technique and two- and three-dimensional ultrasonography. Dig Dis Sci 50 (2005) 1654-1660
61. Talley N.J., Meineche-Schmidt V., Pare P., et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials. The Bond and Opera studies. Aliment Pharmacol Ther 12 (1998) 1055-1065
62. Degen L., Matzinger D., Merz M., et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 15 (2001) 1745-1751
63. Perkel M.S., Moore C., Hersh T., et al. Metoclopramide therapy in patients with delayed gastric emptying. Dig Dis Sci 24 (1979) 662-666
64. McCallum R.W., Ricci D.A., Rakatansky H., et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care 6 (1983) 463-467
65. Patterson D., Abell T., Rothstein R., et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 94 (1999) 1230-1234
66. Abell T.L., Camilleri M., DiMagno E.P., et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 36 (1991) 616-620
67. Richards R.D., Valenzuela G.A., Davenport K.G., et al. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis. Dig Dis Sci 38 (1993) 811-816
68. Kendall B.J., Kendall E.T., Soykan I., et al. Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study. J Int Med Res 25 (1997) 182-189
69. Dutta U., Padhy A.K., Ahuja V., et al. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics. Trop Gastroenterol 20 (1999) 116-119
70. Braden B., Enghofer M., Schaub M., et al. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment Pharmacol Ther 16 (2002) 1341-1346
71. Champion M.C., Gulenchyn K., O'Leary T., et al. Domperidone (Motilium) improves symptoms and solid phase gastric emptying in diabetic gastroparesis. Am J Gastroenterol 82 (1987) 975-980
72. Soykan I., Sarosiek I., and McCallum R.W. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 92 (1997) 976-980
73. Silvers D., Kipnes M., Broadstone V., et al. Domperidone in the management of symptoms of diabetic gastroparesis efficacy, tolerability, and quality-of-live outcomes in a multicenter controlled trial. Clin Ther 20 (1998) 438-453
74. Franzese A., Borrelli O., Corrado G., et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther 16 (2002) 951-957
75. Blum A.L., Arnold R., Stolte M., et al. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut 47 (2000) 473-480
76. Hengels K.J. Therapeutic efficacy of 15 mg lansoprazole mane in 269 patients suffering from non-ulcer dyspepsia (NUD): a multicentre, randomized, double-blind study. Gut 43 (1998) A89
77. Peura D.A., Kovacs T.O.G., Metz D.C., et al. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med 116 (2004) 740-748
78. Wong W.M., Wong B.C., Hung W.K., et al. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 51 (2002) 502-506
79. Bolling-Sternevald E., Lauritsen K., Aalykke C., et al. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 37 (2002) 1395-1402
80. Holtmann G., Talley N.J., Liebregts T., et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354 (2006) 832-840
81. Mertz H., Fass R., Kodner A., et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 93 (1998) 160-165
82. Talley N.J., Camilleri M., Chitkara D.K., et al. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled study. Digestion 72 (2005) 97-103
83. Hamilton J., Guthrie E., Creed F., et al. A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 119 (2000) 661-669
84. Creed F., Fernandes L., Guthrie E., et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124 (2003) 303-317
85. Calvert E.L., Houghton L.A., Cooper P., et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 123 (2002) 1778-1785
86. Chiarioni G., Vantini I., De Iorio F., et al. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther 23 (2006) 1241-1249
87. Talley N.J., Van Zanten S.V., Saez L.R., et al. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 15 (2001) 525-537